ArticleInflammopharmacology2018

Interferon-β inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sjögren's syndrome.

Sarah Benchabane et al.PubMed ↗Publisher ↗

No numbers read from the abstract.